Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Albuminuria, estimated GFR, traditional risk factors, and incident cardiovascular disease: the PREVEND (Prevention of Renal and Vascular Endstage Disease) study.

Smink PA, Lambers Heerspink HJ, Gansevoort RT, de Jong PE, Hillege HL, Bakker SJ, de Zeeuw D.

Am J Kidney Dis. 2012 Nov;60(5):804-11. doi: 10.1053/j.ajkd.2012.06.017.

PMID:
22835901
2.

Estimated glomerular filtration rate and albuminuria as predictors of outcomes in patients with high cardiovascular risk: a cohort study.

Clase CM, Gao P, Tobe SW, McQueen MJ, Grosshennig A, Teo KK, Yusuf S, Mann JF; ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) and TRANSCEND (Telmisartan Randomized Assessment Study in Angiotensin-Converting-Enzyme-Inhibitor Intolerant Subjects with Cardiovascular Disease)..

Ann Intern Med. 2011 Mar 1;154(5):310-8. doi: 10.7326/0003-4819-154-5-201103010-00005.

PMID:
21357908
3.

The combined contribution of albuminuria and glomerular filtration rate to the prediction of cardiovascular mortality in elderly men.

Nerpin E, Ingelsson E, Risérus U, Sundström J, Larsson A, Jobs E, Jobs M, Hallan S, Zethelius B, Berglund L, Basu S, Arnlöv J.

Nephrol Dial Transplant. 2011 Sep;26(9):2820-7. doi: 10.1093/ndt/gfq848.

5.

Clinical risk implications of the CKD Epidemiology Collaboration (CKD-EPI) equation compared with the Modification of Diet in Renal Disease (MDRD) Study equation for estimated GFR.

Matsushita K, Tonelli M, Lloyd A, Levey AS, Coresh J, Hemmelgarn BR; Alberta Kidney Disease Network..

Am J Kidney Dis. 2012 Aug;60(2):241-9. doi: 10.1053/j.ajkd.2012.03.016.

PMID:
22560843
6.

Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis.

Ford I, Bezlyak V, Stott DJ, Sattar N, Packard CJ, Perry I, Buckley BM, Jukema JW, de Craen AJ, Westendorp RG, Shepherd J.

PLoS Med. 2009 Jan 20;6(1):e16. doi: 10.1371/journal.pmed.1000016.

7.

Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.

Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT; PREVEND Study Group..

Nephrol Dial Transplant. 2008 Dec;23(12):3851-8. doi: 10.1093/ndt/gfn356.

8.

Cardiovascular events and all-cause mortality by albuminuria and decreased glomerular filtration rate in patients with vascular disease.

Vlek AL, van der Graaf Y, Spiering W, Algra A, Visseren FL; SMART study group..

J Intern Med. 2008 Oct;264(4):351-60. doi: 10.1111/j.1365-2796.2008.01970.x.

9.

Should eGFR and albuminuria be added to the Framingham risk score? Chronic kidney disease and cardiovascular disease risk prediction.

Chang A, Kramer H.

Nephron Clin Pract. 2011;119(2):c171-7; discussion c177-8. doi: 10.1159/000325669. Review.

10.

Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study.

Hallan S, Astor B, Romundstad S, Aasarød K, Kvenild K, Coresh J.

Arch Intern Med. 2007 Dec 10;167(22):2490-6.

PMID:
18071172
11.

Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population.

Astor BC, Hallan SI, Miller ER 3rd, Yeung E, Coresh J.

Am J Epidemiol. 2008 May 15;167(10):1226-34. doi: 10.1093/aje/kwn033.

12.

Estimated GFR and incident cardiovascular disease events in American Indians: the Strong Heart Study.

Shara NM, Wang H, Mete M, Al-Balha YR, Azalddin N, Lee ET, Franceschini N, Jolly SE, Howard BV, Umans JG.

Am J Kidney Dis. 2012 Nov;60(5):795-803. doi: 10.1053/j.ajkd.2012.06.015.

13.

Influence of age and measure of eGFR on the association between renal function and cardiovascular events.

van der Velde M, Bakker SJ, de Jong PE, Gansevoort RT.

Clin J Am Soc Nephrol. 2010 Nov;5(11):2053-9. doi: 10.2215/CJN.08851209.

14.

Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.

Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS.

Ann Intern Med. 2006 Aug 15;145(4):237-46.

PMID:
16908914
15.

Prognostic significance of a reduced glomerular filtration rate and interaction with microalbuminuria in resistant hypertension: a cohort study.

Salles GF, Cardoso CR, Pereira VS, Fiszman R, Muxfeldt ES.

J Hypertens. 2011 Oct;29(10):2014-23. doi: 10.1097/HJH.0b013e32834adb09.

PMID:
21873887
16.

Relation of baseline presence and severity of renal disease to long-term mortality in persons with known stroke.

Ani C, Ovbiagele B.

J Neurol Sci. 2010 Jan 15;288(1-2):123-8. doi: 10.1016/j.jns.2009.09.020.

PMID:
19853862
17.

Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening.

Halbesma N, Kuiken DS, Brantsma AH, Bakker SJ, Wetzels JF, De Zeeuw D, De Jong PE, Gansevoort RT.

J Am Soc Nephrol. 2006 Sep;17(9):2582-90.

18.

Development and validation of a general population renal risk score.

Halbesma N, Jansen DF, Heymans MW, Stolk RP, de Jong PE, Gansevoort RT; PREVEND Study Group..

Clin J Am Soc Nephrol. 2011 Jul;6(7):1731-8. doi: 10.2215/CJN.08590910.

19.

Cross-sectional survey of the prevalence of reduced estimated glomerular filtration rate, albuminuria and cardiovascular risk in a native Spanish population.

Robles NR, Felix FJ, Fernandez-Berges D, Perez-Castán JF, Zaro MJ, Lozano L, Alvarez-Palacios P, Garcia-Trigo A, Tejero V, Morcillo Y, Hidalgo AB.

J Nephrol. 2013 Jul-Aug;26(4):675-82. doi: 10.5301/jn.5000221.

PMID:
23100180
20.

Decreased glomerular filtration rate is associated with mortality and cardiovascular events in patients with hypertension: a prospective study.

Zhang R, Zheng L, Sun Z, Zhang X, Li J, Hu D, Sun Y.

PLoS One. 2011;6(11):e27359. doi: 10.1371/journal.pone.0027359.

Items per page

Supplemental Content

Support Center